Biotech Communicating Computational Drug Discovery to Investors
Computational drug discovery works best when you explain which bottleneck it actually solves.
Soren Moreau
Contributing Editor
Soren Moreau
Soren Moreau is a contributing editor at HealthTechCrunch covering computational biology drug discovery. Based in Austin, Soren has written for HealthTechCrunch since 2018.
1 story · Austin